Darshana M Dadhania

Darshana M. Dadhania is an Associate Professor of Medicine and Surgery at Weill Cornell Medical College, where she has been a faculty member since 2010. Her work bridges clinical nephrology and transplant immunology, with a strong focus on improving outcomes for kidney transplant recipients through noninvasive diagnostics and biomarker discovery.

• Associate Professor of Medicine, Department of Medicine, Weill Cornell Medical College (2010–present)
• Associate Professor of Surgery, Department of Surgery, Weill Cornell Medical College (2010–present)

Dr. Dadhania's research centers on transplant immunology, noninvasive monitoring of allograft rejection, and microbiota in transplant recipients. She has pioneered work in urinary cell mRNA profiling, cell-free DNA, and transcriptomics to detect acute and chronic rejection without biopsy. Her studies explore the interplay between immunosuppression, infection, and allograft injury, with particular attention to BK virus nephropathy and antibody-mediated rejection.

Her recent publications span high-impact journals such as Nature Medicine, American Journal of Transplantation, and Kidney International. The research consistently emphasizes translational applications, clinical validation, and standardization of diagnostic criteria (e.g., Banff Working Group). She leads or collaborates on multicenter studies and consensus initiatives, reflecting her national and international influence.

• Principal Investigator, APOLLO Network (NIDDK)
• Principal Investigator, Optimization of UroMap (CareDx, Inc.)
• Co-Investigator, Multianalyte Profiling of Kidney Allograft Recipients (CareDx, Inc.)

Dr. Dadhania is actively involved in professional societies, including the American Society of Transplantation, and contributes to clinical education through UpToDate. She has no listed advisees but collaborates extensively with multidisciplinary teams in transplant medicine, nephrology, and surgery.

She maintains a clinical profile at Weill Cornell and is engaged in national efforts to improve transplant care, including frailty assessment, transition of care, and antimicrobial stewardship.